WebNov 9, 2024 · BiomeBank is a clinical stage biotechnology company, founded in South Australia in 2024. About BiomeBank BiomeBank is a clinical stage biotechnology company developing a pipeline of microbiome ... WebDec 9, 2024 · ADELAIDE, Australia, December 09, 2024--BiomeBank today announced the successful capital raise of $10 million following the biotechnology company’s world first regulatory approval of its donor ...
BiomeBank - SA Pathology
WebJul 2, 2024 · BiomeBank, South Australian biotechnology company, has submitted its world-first biologic drug product to the Therapeutic Goods Administration for market authorisation. The product treats recurrent Clostridioides difficile (C-diff) and Ulcerative Colitis and will be used to help meet medical needs across the Asia Pacific. WebIn this episode, hosts Caroline Duell and Dr Rebecca Tunstall, MTPConnect’s Senior Director of Stakeholder Engagement, catch up with BiomeBank, a company out of South Australia. As Australia's first public stool bank and a microbial therapeutics company, it is pioneering new treatments for debilitating bowel conditions. cird staffing costs
Australia
WebBiomeBank is a clinical-stage biotechnology company that focuses on treating and preventing disease by restoring gut microbial ecology. Use the CB Insights Platform to explore BiomeBank's full profile. ... South Australia, 5031, Australia (08) 8152 9370. Suggest an edit ... Australia’s Biomebank is scaling up to meet increasing global … WebBiomeBank is located in Adelaide, South Australia, Australia. Who invested in BiomeBank? BiomeBank has 2 investors including Ellerston Capital and South … WebADELAIDE, Australia-- (BUSINESS WIRE)--BiomeBank today announced the successful capital raise of $10 million following the biotechnology company’s world first regulatory approval of its donor derived microbiome drug product. The funding will allow the biotechnology company to scale its GMP manufacturing facility increasing global supply … cird subcontracting